Hester Biosciences Limited

NSE HESTERBIO.NS

Hester Biosciences Limited Shareholders' Equity for the year ending March 31, 2024: USD 34.98 M

Hester Biosciences Limited Shareholders' Equity is USD 34.98 M for the year ending March 31, 2024, a -1.66% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Hester Biosciences Limited Shareholders' Equity for the year ending March 31, 2023 was USD 35.57 M, a 3.90% change year over year.
  • Hester Biosciences Limited Shareholders' Equity for the year ending March 31, 2022 was USD 34.24 M, a 9.81% change year over year.
  • Hester Biosciences Limited Shareholders' Equity for the year ending March 31, 2021 was USD 31.18 M, a 16.86% change year over year.
  • Hester Biosciences Limited Shareholders' Equity for the year ending March 31, 2020 was USD 26.68 M, a 4.49% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
NSE: HESTERBIO.NS

Hester Biosciences Limited

CEO Mr. Rajiv Dinesh Gandhi B.Com
IPO Date March 13, 2015
Location India
Headquarters Pushpak
Employees 642
Sector Consumers Staples
Industries
Description

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Similar companies

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 19.03

-2.87%

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.35

-2.81%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 25.25

1.60%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 162.23

-1.88%

ERIS.NS

Eris Lifesciences Limited

USD 16.84

1.48%

StockViz Staff

February 9, 2025

Any question? Send us an email